The Scientific Research and Development team at NanoSyrinx is dedicated to innovating and advancing targeted drug delivery systems through rigorous scientific inquiry and experimentation. This interdisciplinary group, comprised of experts in protein engineering and biologic systems, collaborates to design, optimize, and validate novel delivery mechanisms that enhance therapeutic efficacy and minimize side effects. Their work is pivotal in translating cutting-edge research into practical solutions for improving patient outcomes in the biologic delivery sector.
Andy Topping
Scientific Advisor
Callum Tebbatt
Senior Scientist
Fiona Okonjo
Staff Scientist
Hasan M Khan
Scientist I
Kiran Chintakayala
Associate Principal Scientist ...
Marie Mcavoy
Chief Scientific Officer
Nicholas Waterfield
Scientific Advisor & Co-Founde...
Pete Charlton
Scientific Advisor
Sabine Bowman-Grahl
Principal Scientist - Protein ...
View all